Abiopharma

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

New Form SCHEDULE 13D/A - Innovative Eyewear Inc Filed: 2026-01-07 AccNo: 0001376474-26-000025 Size: 58 KB

Galkin Vladimir 🔴 sold 647.5K shares of Innovative Eyewear Inc (LUCY) at $1.79 ($1.2M) Transaction Date: Jan 02, 2026 | Filing ID: 000024

Zuga Matt 🔴 sold 14.9K shares of Acumen Pharmaceuticals, Inc. (ABOS) at $2.00 Transaction Date: Jan 05, 2026 | Filing ID: 001265

Siemers Eric 🔴 sold 10.8K shares of Acumen Pharmaceuticals, Inc. (ABOS) at $1.97 Transaction Date: Jan 05, 2026 | Filing ID: 001264

Director OConnell Daniel Joseph 🔴 sold 47.5K shares of Acumen Pharmaceuticals, Inc. (ABOS) at $1.99 Transaction Date: Jan 05, 2026 | Filing ID: 001263

Meisner Derek M 🔴 sold 26.7K shares of Acumen Pharmaceuticals, Inc. (ABOS) at $1.99 Transaction Date: Jan 05, 2026 | Filing ID: 001262

Barton Russell 🔴 sold 9.3K shares of Acumen Pharmaceuticals, Inc. (ABOS) at $1.99 Transaction Date: Jan 05, 2026 | Filing ID: 001261

SCENESSE® efficacy in vitiligo: new cases presented at RDTC Conference

📋 Norrett Kevin (Officer) plans to sell 6K shares of CODEXIS, INC. (at $1.70 each, total $10K) Filed: Jan 07, 2026 | ID: 000001

SBLENDORIO GLENN 🟢 acquired 45.0K shares (1 derivative) of 4D Molecular Therapeutics, Inc. (FDMT) at $7.30 Transaction Date: Jan 05, 2026 | Filing ID: 006809